CUSIP: 45168K306
Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
23,044,776
-
Share change
-
+1,000
-
Total reported value
-
$106,500,000
-
Price per share
-
$4.63
-
Number of holders
-
40
-
Value change
-
+$5,000
-
Number of buys
-
1
Quarterly Holders Quick Answers
What is CUSIP 45168K306?
CUSIP 45168K306 identifies IDRA - IDERA PHARMACEUTICALS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45168K306:
Institutional Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q4 2013
As of 31 Dec 2013,
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,044,776 shares.
The largest 10 holders included
Broadfin Capital, LLC, MILLENNIUM MANAGEMENT LLC, HealthCor Management, L.P., BAKER BROS. ADVISORS LP, NATIXIS, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Ghost Tree Capital, LLC, EAM Investors, LLC, and BANK OF AMERICA CORP /DE/.
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.